Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

By: Investing.com

Sep 30 2024
1
256 Views

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

By Jennifer Rigby and Michael Erman
LONDON (Reuters) - Pfizer (NYSE:PFE) has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the worlds… [+2955 chars]

Breakthrough: Will DCGI-approved Entod Pharma's PresVu eyedrops eliminate need for reading glasses?

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

The Peanut Allergy Vaccine

Biotech Alert: Searches spiking for these stocks today

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

Biopharmaceutical Processing Equipment and Consumables Research Report 2024-2031: Lucrative Opportunities in Emerging Economies, Shift Toward Bioprocessing 4.0, & Adoption of Personalized Medicines

Amazy contains hidden drug ingredients

Using AI to repurpose existing drugs for treatment of rare diseases

Study: Companies In States Legal For Medical Cannabis Could Save Thousands In Health Premiums

Researchers harness AI to repurpose existing drugs for treatment of rare diseases

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Related